Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karolina Grochowska"'
Autor:
Henrik O Berdel, Hongyu Yin, Jun Yao Liu, Karolina Grochowska, Christopher Middleton, Nathan Yanasak, Rafik Abdelsayed, Wolfgang E Berdel, Mahmood Mozaffari, Jack C Yu, Babak Baban
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113795 (2014)
PURPOSE:The inhibition of serum glucocorticoid-regulated kinase-1 (SGK-1) has been found to decrease growth of colon and prostate cancer cells. The purpose of this study is to evaluate the therapeutic effect of SGK-1 inhibition in head and neck squam
Externí odkaz:
https://doaj.org/article/57de13284e7540e0971badd857ac92fe
Publikováno v:
Hypertension. 60
Damage-associated molecular patterns (DAMPs) are released following tissue injury and cell death and can activate pro-inflammatory pathways. Prototypical DAMPs include the high-mobility group box 1 (HMGB1) protein which is released from necrotic cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::767bce1dd129439945dff49e4ff42504
https://doi.org/10.1161/hyp.60.suppl_1.a442
https://doi.org/10.1161/hyp.60.suppl_1.a442
Autor:
Karolina Grochowska, Nathan Yanasak, Babak Baban, Wolfgang E. Berdel, Hongyu Yin, Jun Yao Liu, Henrik O Berdel, Mahmood S. Mozaffari, Jack C. Yu, Rafik A. Abdelsayed, Christopher L. Middleton
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113795 (2014)
PLoS ONE
PLoS ONE
Purpose The inhibition of serum glucocorticoid-regulated kinase-1 (SGK-1) has been found to decrease growth of colon and prostate cancer cells. The purpose of this study is to evaluate the therapeutic effect of SGK-1 inhibition in head and neck squam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39f3463296ac2b074bf7421745185ef
https://doi.org/10.1371/journal.pone.0113795
https://doi.org/10.1371/journal.pone.0113795
Autor:
Jun Yao Liu, Jeffrey R. Lee, Mahmood S. Mozaffari, Babak Baban, Mei Zheng, Karolina Grochowska
Publikováno v:
The EPMA Journal
Scientific objective Head and neck cancers (HNC) are among the most prevalent and deadly cancers. Despite advances in treatment and improvement in patient’s quality of life, survival rates have not improved in these patients. Increasing evidence sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63ab96bea97b46589b67323974c9688
http://europepmc.org/articles/PMC4125887
http://europepmc.org/articles/PMC4125887